The Claim
Men have lower baseline levels of beta-carotene than women, and this difference contributes to the observed variation in cancer outcomes following antioxidant supplementation.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Men have lower baseline levels of beta-carotene than women, and this difference is associated with different cancer outcomes after antioxidant supplementation.
See the scientific wording
Men may have lower baseline levels of beta-carotene compared to women, which could explain the observed gender difference in cancer outcomes following antioxidant supplementation.
Men start with less beta-carotene in their blood than women, so their cells experience more damage from harmful molecules called free radicals. This damage causes mutations in DNA, which can lead to cancer. When men take beta-carotene supplements, it restores their antioxidant levels, stops the DNA damage, and reduces cancer development.
What the research says
1 studyThe study found that antioxidant pills helped men avoid cancer more than women, and the researchers think this might be because men started with less beta-carotene in their blood. So yes, the study supports the idea that men may have lower levels to begin with.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.